Interestingly, contrary to VSV, intratumoral injection of a replication-defective adenovirus expressing CD40L (Ad-CD40L) resulted in a more efficient anti-tumour response in comparison to both replication-competent VSV-GFP and VSV-CD40L. This evidence concerns the gene CD40LG and neoplasm.